Clinical Trials

Phase 2 Not yet recruiting

1,295 enrolled

Breast

Anatomic Stage II Breast Cancer AJCC v8

NCT07625527 2026-06-04

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

120 enrolled

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT04519879 2026-06-03

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Phase 2 Suspended

133 enrolled

Prostatic Neoplasms

NCT05375617 2026-06-02

EPICkids

CNSLymphoidOther hematologic neoplasm

1,400 enrolled

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05976763 2026-06-02

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

421 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT07613385 2026-05-29

Individualized AML Treatment

Other hematologic neoplasm

18 enrolled

Leukemia, Myeloid, Acute

NCT00949819 2026-05-26

ASCaP

462 enrolled

Prostatic Neoplasms

NCT06974370 2026-05-26

ACTION-Brain

45 enrolled

Brain Neoplasms

NCT06998342 2026-05-26

MOHSAHRTSS

24 enrolled

Head and Neck Neoplasms

NCT07023432 2026-05-22

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

78 enrolled

Phase EARLY_PHASE1 Recruiting

Carcinoma, Renal Cell

NCT03594630 2026-05-20

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

120 enrolled

Rectal Neoplasms

NCT07513389 2026-05-20

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

36 enrolled

Phase 3 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT07591493 2026-05-15

ADJUPANET

300 enrolled

EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Phase 4 Recruiting

600 enrolled

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07576842 2026-05-08

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

750 enrolled

Phase 2/3 Active not recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02135042 2026-05-07

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

685 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT02609685 2026-05-07

PMCAS

216 enrolled

Papillary Thyroid Microcarcinoma, Thyroid Neoplasms

NCT03180268 2026-05-07

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

163 enrolled

Phase 3 Active not recruiting

Meningioma

NCT06745024 2026-05-04

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

280 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT03803553 2026-05-01

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

400 enrolled

Colonic Neoplasms

NCT06792994 2026-04-30

CLL2000

LymphoidOther hematologic neoplasm

2,000 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07547163 2026-04-23

LGG PRO's

90 enrolled

Glioma

NCT06378866 2026-04-20

DIVINE

532 enrolled

Prostatic Neoplasms

NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

38 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

200 enrolled

Dermatologic

Carcinoma, Basal Cell

NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

125 enrolled

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT07270861 2026-03-24

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

3,000 enrolled

Lymphoid

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT05343936 2026-03-18

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Active not recruiting

490 enrolled

Prostatic Neoplasms

NCT04344899 2026-03-11

PORTS

Completed

74 enrolled

Pelvic Neoplasms

NCT07457099 2026-03-09

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

Not yet recruiting

85 enrolled

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04425421 2026-03-02

GFALMB2019

1,000 enrolled

Lymphoid

Burkitt Lymphoma

NCT04425434 2026-03-02

GFARB12019

3,000 enrolled

Other solid neoplasm

Retinoblastoma

NCT05840484 2026-02-19

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

100 enrolled

Phase 4 Not yet recruiting

Prostatic Neoplasms

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Endometrial Neoplasms

NCT03516617 2026-02-09

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

LymphoidOther hematologic neoplasm

120 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05333874 2026-02-09

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Phase EARLY_PHASE1 Active not recruiting

34 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05810467 2026-02-04

AS

200 enrolled

Prostatic Neoplasms

NCT07370675 2026-01-27

Active Surveillance for Bethesda IV Thyroid Nodules

165 enrolled

Phase 2/3 Active not recruiting

Thyroid Neoplasms, Thyroid Nodule

NCT05710406 2026-01-26

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

1 enrolled

Phase EARLY_PHASE1 Recruiting

Colonic Neoplasms

NCT07025226 2026-01-26

Senolytics

10 enrolled

Phase NA Active not recruiting

Glioma

NCT02914873 2026-01-20

PCASTT

2,008 enrolled

Phase NA Active not recruiting

Prostatic Neoplasms

NCT06411938 2026-01-16

Merck-3

2,300 enrolled

Phase NA Not yet recruiting

Uterine Cervical Neoplasms

NCT07240220 2026-01-15

Merck-4

2,500 enrolled

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT07262138 2025-12-03

ACTIVE

50 enrolled

Breast

Breast Neoplasms

NCT02882282 2025-10-23

Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia

Phase 2 Completed

15 enrolled 8 charts

Mouth Neoplasms

NCT06200103 2025-09-11

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

236 enrolled

Prostatic Neoplasms

NCT03911128 2025-09-02

A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

LymphoidOther hematologic neoplasm

500 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04467489 2025-08-11

Biomarkers of CASH

Active not recruiting

1,040 enrolled

Hemangioma, Cavernous, Hemangioma, Cavernous, Central Nervous System

NCT06537154 2025-07-30

NEO-BLAST

Phase 2/3 Recruiting

688 enrolled

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT06861894 2025-05-15

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

164 enrolled